Biosurgery Market by Product (Adhesion Barriers, Bone Graft Attachments, Hemostatic Agents), Source (Biologics Products, Synthetic Products), Application, End-Users - Global Forecast 2024-2030

Biosurgery Market by Product (Adhesion Barriers, Bone Graft Attachments, Hemostatic Agents), Source (Biologics Products, Synthetic Products), Application, End-Users - Global Forecast 2024-2030


The Biosurgery Market size was estimated at USD 15.13 billion in 2023 and expected to reach USD 16.35 billion in 2024, at a CAGR 8.17% to reach USD 26.22 billion by 2030.

Global Biosurgery Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biosurgery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biosurgery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biosurgery Market, highlighting leading vendors and their innovative profiles. These include Aroa Biosurgery Limited, Artivion, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson, and Company, Boston Scientific Corporation, Cabaletta Bio, Inc., CSL Limited, Getinge AB, Hemostasis, LLC, Integra LifeSciences Corporation, Johnson & Johnson Services Inc., Kuros Bioscience AG, Medtronic PLC, Ocular Therapeutix, Inc., Orthofix Medical, Inc., Pfizer Inc., RTI Surgical, Inc., Samyang Holdings Corporation, Sanofi SA, Smith & Nephew plc, Stryker Corporation, Tissue Regenix Ltd, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage



This research report categorizes the Biosurgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Adhesion Barriers
Bone Graft Attachments
Hemostatic Agents
Soft Tissue Attachments
Surgical Sealants
Source
Biologics Products
Synthetic Products
Application
Cardiovascular Surgery
General Surgery
Gynecology Surgery
Neurological Surgery
Orthopedic Surgery
Thoracic Surgery
Urology Surgery
End-Users
Clinics
Hospitals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biosurgery Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biosurgery Market?
3. What are the technology trends and regulatory frameworks in the Biosurgery Market?
4. What is the market share of the leading vendors in the Biosurgery Market?
5. Which modes and strategic moves are suitable for entering the Biosurgery Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Biosurgery Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising geriatric population and increase in the volume of minimal-invasive surgeries
5.1.1.2. Growing need for effective blood loss management in patients
5.1.1.3. Increase in investments by the government in the biosurgery
5.1.2. Restraints
5.1.2.1. Concern associated with high cost of biosurgery
5.1.3. Opportunities
5.1.3.1. Introduction of advanced and tech-driven biosurgery products
5.1.3.2. Potential development of medical tourism and rise in need for advanced bio materials
5.1.4. Challenges
5.1.4.1. Stringent regulatory framework and dearth of clinical expertise
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Biosurgery Market, by Product
6.1. Introduction
6.2. Adhesion Barriers
6.3. Bone Graft Attachments
6.4. Hemostatic Agents
6.5. Soft Tissue Attachments
6.6. Surgical Sealants
7. Biosurgery Market, by Source
7.1. Introduction
7.2. Biologics Products
7.3. Synthetic Products
8. Biosurgery Market, by Application
8.1. Introduction
8.2. Cardiovascular Surgery
8.3. General Surgery
8.4. Gynecology Surgery
8.5. Neurological Surgery
8.6. Orthopedic Surgery
8.7. Thoracic Surgery
8.8. Urology Surgery
9. Biosurgery Market, by End-Users
9.1. Introduction
9.2. Clinics
9.3. Hospitals
10. Americas Biosurgery Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Biosurgery Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Biosurgery Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Aroa Biosurgery Limited
14.1.2. Artivion, Inc.
14.1.3. B. Braun Melsungen AG
14.1.4. Baxter International Inc.
14.1.5. Becton, Dickinson, and Company
14.1.6. Boston Scientific Corporation
14.1.7. Cabaletta Bio, Inc.
14.1.8. CSL Limited
14.1.9. Getinge AB
14.1.10. Hemostasis, LLC
14.1.11. Integra LifeSciences Corporation
14.1.12. Johnson & Johnson Services Inc.
14.1.13. Kuros Bioscience AG
14.1.14. Medtronic PLC
14.1.15. Ocular Therapeutix, Inc.
14.1.16. Orthofix Medical, Inc.
14.1.17. Pfizer Inc.
14.1.18. RTI Surgical, Inc.
14.1.19. Samyang Holdings Corporation
14.1.20. Sanofi SA
14.1.21. Smith & Nephew plc
14.1.22. Stryker Corporation
14.1.23. Tissue Regenix Ltd
14.1.24. Zimmer Biomet Holdings, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. BIOSURGERY MARKET RESEARCH PROCESS
FIGURE 2. BIOSURGERY MARKET SIZE, 2023 VS 2030
FIGURE 3. BIOSURGERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BIOSURGERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BIOSURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOSURGERY MARKET DYNAMICS
FIGURE 7. BIOSURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. BIOSURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BIOSURGERY MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 10. BIOSURGERY MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BIOSURGERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. BIOSURGERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. BIOSURGERY MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 14. BIOSURGERY MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. BIOSURGERY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. BIOSURGERY MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings